MDM Templates
Endocarditis — Right-Sided (IVDU)
Patient with history of IV drug use presents with fever and *** in the setting of active or recent drug use. Clinical presentation is concerning for right-sided endocarditis involving the tricuspid valve. Exam reveals ***, consistent with acute valvular pathology and hemodynamic stress. Well appearing without signs of acute decompensated heart failure or septic shock.
History, exam, and preliminary workup lower suspicion for acute coronary syndrome, acute stroke, and left-sided endocarditis with systemic emboli (no focal neurologic deficits, no signs of peripheral vascular occlusion). Blood cultures sent. Echocardiography ordered to evaluate for vegetations and right ventricular function; if clinical suspicion remains high and transthoracic echo is nondiagnostic, transesophageal echo will be pursued.
Plan: Empiric antibiotic therapy initiated with vancomycin 15-20 mg/kg IV every 8-12 hours (target trough 15-20 mcg/mL) plus ceftriaxone 2 g IV every 12 hours. Blood culture results will guide definitive organism-targeted therapy. Infectious disease consulted regarding duration, organism-specific dosing, and need for adjunctive therapy. Serial echocardiography planned. Septic pulmonary emboli anticipated — monitor oxygenation closely and arrange ICU-level monitoring.
Disposition: Admit to ICU for continuous cardiac monitoring, antibiotic initiation, and hemodynamic management. Early ID and cardiothoracic surgery consultation given risk of mechanical complications.
Endocarditis — Left-Sided (Native Valve)
Patient presents with fever, constitutional symptoms, and *** in the setting of predisposing cardiac condition (***). Clinical presentation is concerning for left-sided endocarditis. Exam notable for ***. History and presentation raise concern for systemic embolic phenomena — stroke, peripheral arterial occlusion, splenic or mesenteric infarction.
History, exam, and available imaging lower suspicion for sepsis from other source (pneumonia, UTI, abdomen) as the primary etiology. Blood cultures sent. Echocardiography ordered with consideration for transesophageal echo given higher sensitivity; CT head obtained to evaluate for embolic stroke if any focal neuro findings present.
Plan: Empiric antibiotic therapy initiated with vancomycin 15-20 mg/kg IV every 8-12 hours plus ceftriaxone 2 g IV every 12 hours. Blood culture results will guide organism-targeted adjustments. Infectious disease, cardiology, and cardiothoracic surgery consulted. Stroke risk significant — neurology involvement if imaging shows embolic phenomena. Serial echocardiography planned to assess for complications (vegetation growth, paravalvular abscess, new regurgitation).
Disposition: Admit to ICU for continuous monitoring, antibiotic therapy, and close observation for hemodynamic deterioration or embolic events. Surgical consultation obtained early given high risk of valve rupture or prosthetic dehiscence requiring operative intervention.
Endocarditis — Prosthetic Valve
Patient with history of prosthetic valve replacement presents with fever and *** in the timeframe of *** (recent surgery vs remote). Clinical presentation concerning for prosthetic valve endocarditis. Mortality higher than native valve disease; organisms broader and often resistant.
History and exam lower suspicion for mechanical valve malfunction from thrombosis or pannus, though both remain on differential. Blood cultures sent. Echocardiography obtained with low threshold for transesophageal echo given superior sensitivity in detecting paravalvular abscesses and loose sutures — findings that directly impact surgical decision-making.
Plan: Empiric antibiotic therapy initiated with vancomycin 15-20 mg/kg IV every 8-12 hours, gentamicin 1 mg/kg IV every 8 hours, and rifampin 600 mg IV/PO every 6-8 hours (broader coverage for coagulase-negative staph and other resistant gram-positive organisms common in prosthetic infection). Blood culture results will guide organism-targeted de-escalation after 48-72 hours. Infectious disease and cardiothoracic surgery consulted immediately — high threshold for operative intervention in prosthetic endocarditis.
Disposition: Admit to ICU for hemodynamic monitoring, antibiotic initiation, and early surgical consultation. Many prosthetic valve infections ultimately require operative intervention (valve replacement); do not delay surgical team involvement.
Clinical Education
Modified Duke Criteria for Endocarditis Diagnosis
Endocarditis diagnosis hinges on the Modified Duke Criteria, which combine clinical, echocardiographic, and microbiological evidence. Diagnosis requires either two major criteria, one major and three minor criteria, or five minor criteria. The criteria have high sensitivity and specificity and serve as the consensus standard for diagnosis in emergency and inpatient settings.
| Major Criteria | Definition |
| Positive blood cultures | Two or more sets with typical organism (Streptococcus viridans, Staph aureus, Streptococcus bovis, HACEK group) OR persistent positive culture (≥3 of 4 sets, first and last separated by ≥1 hour) |
| Endocardial involvement on imaging | Vegetation on echocardiography, paravalvular abscess, prosthetic valve dehiscence, or new regurgitation on echo |
| Minor Criteria | |
| Predisposing cardiac condition | Known valvular disease, prosthetic valve, congenital defect, patent foramen ovale, hypertrophic cardiomyopathy |
| Fever ≥38°C | Temperature ≥38.0°C at presentation |
| Vascular phenomena | Arterial emboli, septic pulmonary emboli, mycotic aneurysm, splinter hemorrhages (Osler nodes if painless, Janeway lesions if painful) |
| Immunologic phenomena | Glomerulonephritis, Osler nodes (painful fingertip nodules), Roth spots (retinal hemorrhages) |
| Suggestive microbiological finding | Positive single blood culture or serology for agent consistent with endocarditis |
Clinical pearl: Do not wait for Duke criteria to be fully met before starting antibiotics. If clinical suspicion is high (fever, new murmur, risk factors), blood cultures should be drawn immediately and empiric therapy started without delay. Waiting for imaging or culture confirmation results increases morbidity and mortality.
Microbiology and Risk Stratification
Staph aureus is the most common cause of endocarditis overall and dominates in IV drug users. In IVDU with right-sided endocarditis, Staph aureus accounts for 60-70% of cases. Methicillin-resistant strains (MRSA) are increasingly prevalent, necessitating vancomycin as empiric therapy in all cases until susceptibilities are known [1].
Streptococcus viridans (alpha-hemolytic) is the most common cause of subacute native valve endocarditis in non-IVDU patients, typically affecting those with underlying valvular disease (rheumatic heart disease, degenerative valve disease). It is typically susceptible to penicillin and cephalosporins but may show reduced susceptibility requiring higher doses or combination therapy.
Streptococcus bovis (now classified as Streptococcus gallolyticus) is associated with bacteremia and endocarditis, particularly in patients with colon cancer or colonic polyps. Its isolation from blood cultures warrants screening colonoscopy.
HACEK organisms (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella) are fastidious gram-negative bacteria that require special culture conditions and a longer period to grow. They cause 5-10% of community-acquired endocarditis and typically affect native valves. Ceftriaxone is the agent of choice.
Coagulase-negative staphylococci (particularly Staphylococcus epidermidis) are the leading cause of early prosthetic valve endocarditis (within 60 days of surgery), often originating from intraoperative contamination. Late prosthetic endocarditis may resemble native valve disease but coagulase-negative staph remains a significant pathogen requiring empiric coverage with vancomycin and gentamicin.
Enterococci and gram-negative organisms are uncommon but carry high mortality. Consider these when standard organisms are not isolated or when clinical deterioration occurs despite appropriate therapy.
Physical Examination Findings
Roth spots are retinal hemorrhages with white centers (septic emboli or immune complexes) visualized on fundoscopic exam. They are classic but uncommonly found; their presence is highly specific for endocarditis when present.
Osler nodes are tender nodules on the finger or toe pads resulting from immune complex deposition in dermal tissues. They appear as painful, pea-sized lesions and are more common in subacute endocarditis. Often multiple and appear on multiple digits.
Janeway lesions are painless erythematous macules on the palms and soles of the feet resulting from septic microemboli. Unlike Osler nodes, they do not blanch with pressure and are entirely painless. They appear early in acute endocarditis and resolve as inflammation subsides.
Splinter hemorrhages are linear streaks under the fingernails from septic emboli lodging in capillaries of the nail bed. They may be nonspecific (trauma, psoriasis) or highly specific depending on distribution and context, but their presence in the setting of fever and risk factors supports the diagnosis.
New or changing cardiac murmur: A new regurgitant murmur (aortic or mitral insufficiency) indicates valve damage from infection and is a major criterion. The murmur of acute aortic regurgitation from vegetation or perforation is typically early diastolic and may be subtle.
Right-Sided vs Left-Sided Endocarditis
Right-sided endocarditis is strongly associated with IVDU and typically involves the tricuspid valve. Septic pulmonary emboli are the hallmark — vegetations fragment and lodge in pulmonary arteries, causing multiple small pulmonary infarcts presenting with chest pain, hemoptysis, and pulmonary infiltrates on imaging. Right-sided disease carries a better prognosis (mortality 5-15% with appropriate therapy) because the lower pressures on the right side minimize acute hemodynamic decompensation. However, septic emboli to the lungs are frequent and serious.
Left-sided endocarditis (mitral or aortic valve) poses far greater immediate risk. High-pressure left-sided jets create turbulent flow and larger vegetations. Septic emboli to the systemic circulation cause stroke, splenic infarction, mesenteric ischemia, and peripheral arterial occlusion. Mortality is significantly higher (15-30% or more) because acute valve insufficiency leads to pulmonary edema and cardiogenic shock. Aortic insufficiency from aortic valve endocarditis can cause acute decompensation within hours.
Prosthetic valve endocarditis is uniquely aggressive. Early prosthetic disease (within 60 days) is typically nosocomial and caused by resistant organisms (coagulase-negative staph, gram-negative bacilli). Late prosthetic endocarditis (>60 days) may resemble community-acquired native valve disease but carries higher mortality. Paravalvular abscesses (collections around the valve sewing ring) can erode into surrounding tissue and conducting system, causing conduction abnormalities. Prosthetic valve dehiscence (mechanical loosening of the prosthesis) may require emergent surgical replacement. Mortality exceeds 40% even with optimal medical and surgical therapy.
Empiric Antibiotic Regimens
| Clinical Setting | Empiric Regimen | Duration |
| Native valve (any valve) | Vancomycin 15-20 mg/kg IV Q8-12h (target trough 15-20) PLUS Ceftriaxone 2 g IV Q12h | 4-6 weeks depending on organism |
| Prosthetic valve (early or late) | Vancomycin 15-20 mg/kg IV Q8-12h PLUS Gentamicin 1 mg/kg IV Q8h PLUS Rifampin 600 mg IV/PO Q6-8h | 6+ weeks; surgical intervention frequently required |
| IVDU/right-sided | Vancomycin 15-20 mg/kg IV Q8-12h PLUS Ceftriaxone 2 g IV Q12h | 4-6 weeks (shorter courses debated if excellent compliance and follow-up) |
Rationale for vancomycin: Covers both susceptible and resistant Streptococcus species, Staph aureus including MRSA, and Enterococcus (partially). Target trough of 15-20 mcg/mL ensures adequate CNS penetration and intracellular killing. Ceftriaxone adds coverage of HACEK organisms and provides excellent bone and endocardial penetration.
Prosthetic valve triple therapy: Gentamicin is added because coagulase-negative staph and other gram-positive rods are often resistant to beta-lactams alone. Rifampin is added for its excellent intracellular penetration and biofilm penetration — critical for organisms that may be sequestered within prosthetic material. Gentamicin duration is typically limited to the first 2 weeks due to nephrotoxicity risk [2].
Organism-specific de-escalation: Once culture and susceptibilities are known, therapy is tailored. Penicillin-susceptible Streptococcus viridans may be treated with penicillin or ceftriaxone monotherapy. Staph aureus susceptibility determines whether vancomycin or nafcillin is used. HACEK organisms require ceftriaxone or cefotaxime. Never de-escalate empirically before confirmatory culture results are available.
Surgical Indications
Approximately 50% of endocarditis patients ultimately require operative intervention. Indications include acute heart failure from valve rupture or severe regurgitation (must not be delayed for prolonged antibiotic therapy), uncontrolled infection despite appropriate antibiotics, large vegetations (>10 mm), prosthetic valve dehiscence or paravalvular abscess, fungal endocarditis, and recurrent septic emboli despite appropriate therapy.
Heart failure is the most urgent indication. A patient with acute aortic regurgitation causing pulmonary edema and hemodynamic instability cannot wait weeks for antibiotics to sterilize the valve. Emergent cardiothoracic consultation and valve replacement may be lifesaving.
Prosthetic valve endocarditis with any structural complication (dehiscence, paravalvular abscess, vegetations >10 mm) typically requires surgery. The integrity of the prosthesis is compromised, and further damage risks complete valve failure or embolic shower.
Uncontrolled infection despite appropriate antibiotics for ≥7-10 days, evidenced by persistent fever, inflammatory markers, and failure to clear blood cultures, suggests either inadequate drug levels, unusual organism, or mechanical complication requiring intervention.
Large vegetations (>10 mm) carry higher risk of systemic embolization. Some experts advocate for earlier surgery with large vegetations to prevent stroke or other embolic complications, particularly in left-sided disease.
Fungal endocarditis (rare in community setting but increasingly seen in ICU patients and post-cardiac surgery) almost always requires surgical intervention because fungal organisms are resistant to medical therapy.
Echo Strategy: TTE vs TEE
Transthoracic echocardiography (TTE) should be the first imaging modality in suspected endocarditis because it is non-invasive, rapidly available, and may identify vegetations, regurgitation, or evidence of heart failure. TTE has approximately 60% sensitivity for vegetation detection. It is particularly useful for evaluating right-sided disease (tricuspid vegetations may be large and easily visualized) and global cardiac function.
Transesophageal echocardiography (TEE) has superior sensitivity (95%) for vegetation detection and is essential for visualizing the left side of the heart, detecting paravalvular abscesses, assessing prosthetic valve integrity, and evaluating for perforation. TEE should be performed if TTE is nondiagnostic but clinical suspicion remains high, if prosthetic valve disease is suspected, or if complications (abscess, dehiscence) are being evaluated.
Clinical strategy: Obtain TTE in all suspected endocarditis patients within 24 hours. If TTE is positive and clinical picture is consistent, proceed with antibiotics and ID consultation without delay. If TTE is nondiagnostic but clinical suspicion is high, perform TEE. In prosthetic valve endocarditis or if complications are suspected clinically, TEE should be considered even if TTE is positive to fully characterize the extent of disease and guide surgical planning [3].
Serial echocardiography is useful to assess response to therapy (vegetation regression) and to detect emerging complications. Do not perform daily or every-other-day echos routinely; serial imaging typically occurs at 1-2 week intervals unless clinical deterioration prompts earlier reassessment.
References
- Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293(24):3012-3021. PubMed 15956130
- Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force of the European Society of Cardiology (ESC). Eur Heart J. 2015;36(44):3075-3128. PubMed 26320109
- Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2017;135(25):e1159-e1195. PubMed 28298458
- Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162(1):90-94. PubMed 11784223
- Tornos P. Blood culture negative endocarditis. Heart. 2004;90(9):1063-1068. PubMed 15310733
tydotphrase.com 